/resources

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:  
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA 
www.X.com/PhRMA 

This virtual event launched the AMR Action Fund, a partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The fund will invest approximately $1 billion to ensure a robust and diverse pipeline of new medicines to treat drug-resistant infections. 

Visit www.AMRActionFund.com to learn more.

Speakers (in order of appearance):

• David Ricks, Chairman and CEO, Eli Lilly and Company
• Michelle McMurry-Heath, President and CEO, BIO
• Brandon Noble, former NFL player
• Stephen J. Ubl, President and CEO, PhRMA
• Ken Frazier, Chairman and CEO, Merck
• Albert Bourla, Chairman and CEO, Pfizer
• Priscilla VanderVeer, Vice President, PhRMA
• ADM Brett P. Giroir, MD, Assistant Secretary for Health
• Senator Bob Casey (D-PA)
• Senator Bill Cassidy, MD (R-LA)
• Scott Gottlieb, resident fellow, American Enterprise Institute – moderator
• Helen Boucher, MD, board member and treasurer, Infectious Disease Society of America
• Kathy Talkington, director, Health Programs, The Pew Charitable Trusts
• Kevin Outterson, executive director and principal investigator, CARB-X
• Ramani Varanasi, founder/president/CEO, X-Biotix
• Michael Boyle, MD, president and CEO, Cystic Fibrosis Foundation

Event

AMR

Bridging the Gap: New Collaborations to Drive Antimicrobial Innovation

July 9, 2020

Bridging the Gap: New Collaborations to Drive Antimicrobial Innovation image